Volume 58, Issue 4, Pages (October 2010)

Slides:

Advertisements

Similar presentations

Volume 53, Issue 3, Pages (March 2008)

Advertisements

Volume 55, Issue 1, Pages 1-8 (January 2009)

Pascal Rischmann European Urology Supplements

Volume 71, Issue 2, Pages (February 2017)

The PSA Era is not Over for Prostate Cancer

Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D

Volume 59, Issue 2, Pages (February 2011)

Volume 51, Issue 2, Pages (February 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Testosterone Therapy in Men With Prostate Cancer

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 74, Issue 4, Pages (October 2018)

Prostate Cancer: Highlights from 2006

Volume 69, Issue 2, Pages (February 2016)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 65, Issue 5, Pages (May 2014)

Volume 70, Issue 4, Pages (October 2016)

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Volume 71, Issue 2, Pages (February 2017)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 4, Pages (October 2015)

Volume 54, Issue 4, Pages (October 2008)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 54, Issue 5, Pages (November 2008)

Volume 67, Issue 3, Pages (March 2015)

Volume 70, Issue 4, Pages (October 2016)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 67, Issue 6, Pages (June 2015)

Laurent Boccon-Gibod European Urology Supplements

Volume 64, Issue 6, Pages (December 2013)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Volume 53, Issue 6, Pages (June 2008)

Volume 61, Issue 2, Pages (February 2012)

Volume 63, Issue 3, Pages (March 2013)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 68, Issue 4, Pages (October 2015)

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

Volume 50, Issue 5, Pages (November 2006)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 50, Issue 2, Pages (August 2006)

Volume 53, Issue 1, Pages (January 2008)

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Long-Term Hormonal Therapy: Who Would Benefit?

Volume 59, Issue 4, Pages (April 2011)

European Urology is “Your” Journal

Volume 54, Issue 1, Pages (July 2008)

Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill

Volume 53, Issue 6, Pages (June 2008)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Volume 51, Issue 2, Pages (February 2007)

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 58, Issue 4, Pages 559-566 (October 2010) Multicentric Oncologic Outcomes of High-Intensity Focused Ultrasound for Localized Prostate Cancer in 803 Patients Sebastien Crouzet, Xavier Rebillard, Daniel Chevallier, Pascal Rischmann, Gilles Pasticier, Gregory Garcia, Olivier Rouviere, Jean-Yves Chapelon, Albert Gelet European Urology Volume 58, Issue 4, Pages 559-566 (October 2010) DOI: 10.1016/j.eururo.2010.06.037 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 Overall survival rates in 803 patients with localized prostate cancer following treatment with high-intensity focused ultrasound. European Urology 2010 58, 559-566DOI: (10.1016/j.eururo.2010.06.037) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 2 Cancer-specific survival rates in 803 patients with localized prostate cancer following treatment with high-intensity focused ultrasound. European Urology 2010 58, 559-566DOI: (10.1016/j.eururo.2010.06.037) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 3 Metastasis-free survival rates in 803 patients with localized prostate cancer following treatment with high-intensity focused ultrasound. European Urology 2010 58, 559-566DOI: (10.1016/j.eururo.2010.06.037) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 4 Biochemical-free survival rates in patients with localized prostate cancer following treatment with high-intensity focused ultrasound, according to D’Amico risk group. European Urology 2010 58, 559-566DOI: (10.1016/j.eururo.2010.06.037) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 5 Adjuvant treatment-free survival rates in patients with localized prostate cancer following treatment with high-intensity focused ultrasound. European Urology 2010 58, 559-566DOI: (10.1016/j.eururo.2010.06.037) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 6 Disease-free survival rates using combined criteria in patients with localized prostate cancer following treatment with high-intensity focused ultrasound. European Urology 2010 58, 559-566DOI: (10.1016/j.eururo.2010.06.037) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 7 Biochemical-free survival rates in patients with localized prostate cancer following treatment with high-intensity focused ultrasound depending on prostate-specific antigen nadir levels. European Urology 2010 58, 559-566DOI: (10.1016/j.eururo.2010.06.037) Copyright © 2010 European Association of Urology Terms and Conditions